GSEU stock forecast, quote, news & analysis

The most notable companies in this group are Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), BP plc (NYSE:BP), Boeing Company (NYSE:BA), Allergan plc (NYSE:AGN), JD.com (NASDAQ:JD), Suncor Energy (NYSE:SU), Prudential Financial (NYSE:PRU), Newmont Corp (NYSE:NEM), Archer Daniels Midland Company (NYSE:ADM).

The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Goldman Sachs ActiveBeta® Europe Equity Index (the "index"). The index is designed to deliver exposure to equity securities of developed markets issuers in Europe. The fund seeks to achieve its investment objective by investing at least 80% of its assets (exclusive of collateral held from securities lending) in securities included in its underlying index, in depositary receipts representing securities included in its underlying index and in underlying stocks in respect of depositary receipts included in its underlying index.

The average market capitalization across the Goldman Sachs ActiveBeta® Europe Eq ETF ETF is 37.57B. The market cap for tickers in the group ranges from 64.65K to 380.18B. ASML holds the highest valuation in this group at 380.18B. The lowest valued company is BAYN at 64.65K.

The average weekly price growth across all stocks in the Goldman Sachs ActiveBeta® Europe Eq ETF ETF was -2%. For the same ETF, the average monthly price growth was -6%, and the average quarterly price growth was -5%. EVO experienced the highest price growth at 32%, while EBS experienced the biggest fall at -34%.

The average weekly volume growth across all stocks in the Goldman Sachs ActiveBeta® Europe Eq ETF ETF was 14%. For the same stocks of the ETF, the average monthly volume growth was 49% and the average quarterly volume growth was 41%